Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism

Diabetes

Volumn 47, Issue 9, 1998, Pages 1494-1500

  Ishizuka, Tatsuo ^a   Itaya, Satomi ^a   Wada, Hiroaki ^a   Ishizawa, Masayoshi ^a   Kimura, Mika ^a   Kajita, Kazuo ^a   Kanoh, Yoshinori ^a   Miura, Atsushi ^a   Muto, Naoya ^a   Yasuda, Keigo ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; PIOGLITAZONE; TROGLITAZONE;

ARTICLE; DIABETES MELLITUS; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INSULIN RESISTANCE; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION;

EID: 0031685956     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.9.1494     Document Type: Article

References (33)

1. Rittenhouse SE, Simmons ER: Production of diglyceride from phosphatidylinositol in activated platelets. J Clin Invest 63:580-587, 1979
2. Broekman MJ, Ward JW, Marcus AJ: Phospholipid metabolism in stimulated human platelets. J Clin Invest 66:275-283, 1980
3. Billah MM, Lapetina EG: Rapid decrease of phosphatidylinositol 4,5-bisphosphate in thrombin-stimulated platelets. J Biol Chem 25:12705-12708, 1982
4. Imai A, Nakashima S, Nozawa Y: The rapid polyphosphoinositide mediated stimulation of human platelets. Biochem Biophys Res Commun 110:108-115, 1983
5. 2+ mobilization in platelet activation. J Biol Chem 260:15172-15179, 1985
6. Kaibuchi K, Takai Y, Sawamura M, Hoshijima M, Fujikura T, Nishizuka Y: Synergistic functions of protein phosphorylation and calcium mobilization in platelet activation. J Biol Chem 258:6701-6704, 1983
7. Lapetina EG, Reep B, Ganong BR, Bell RM: Exogenous sn-1,2-diacylglycerols containing saturated fatty acids function as bioregulators of protein kinase C in human platelets. J Biol Chem 260:1358-1361, 1985
8. Marcus AJ: The role of lipids in platelets function, with particular reference to the arachidonic acid pathway. J Lipid Res 19:793-826, 1978
9. Bern MM: Platelet function in diabetes mellitus. Diabetes 27:342-350, 1978
10. Colwell JA, Winocour PD, Lopes-Virella M, Halushka PV: New concepts about the pathogenesis of atherosclerosis in diabetes mellitus. Am J Med 75:67-80, 1983
11. Takahashi R, Morita I, Murota S, Shiraki M, Ito M, Orimo H: Dietary arachidonic acid supplementation increases thromboxane synthesizing activity in platelets from diabetes. Prostaglandins Leukot Essent Fatty Acids 75:67-80, 1983
12. Takahashi R, Morita I, Saito Y, Ito H, Murota S: Increased arachidonic acid incorporation into platelet phospholipids in type 2 (non-insulin-dependent) diabetes. Diabetologia 26:134-137, 1984
13. Bastyr EJ, Kadrofske MM, Dershimer RC, Vinik AI: Decreased platelet phosphoinositide turnover and enhanced platelet activation in IDDM. Diabetes 38:1097-1102, 1989
14. 2+ mobilization, and protein phosphorylation in platelets from NIDDM patients. Diabetes 39:1561-1568, 1990
15. Ishizuka T, Yasuda K, Takeda N, Kajita K, Miura K, Nakashima S, Nagao S, Nozawa Y: Thrombin-induced breakdown of phosphoinositides in platelets from patients with NIDDM. Endocrinol Jpn 38:81-87, 1991
16. Fujita, T, Sugiyama Y, Taketomi S, Sohda T, Kawamatsu Y, Iwatsuka H, Suzuoki Z: Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexyhnethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, ciglitazone): a new antidiabetic agent. Diabetes 32:804-810, 1983
17. Fujiwara T, Yoshioka S, Yoshioka T, Ushiyama I, Horikoshi H: Characterization of new oral antidiabetic agent CS-045: studies in KK and ob/ob mice and Zucker fatty rats. Diabetes 37:1549-1558, 1988
18. Kobayashi M, Iwasaki M, Ohgaku S, Maegawa H, Watanabe N, Shigeta Y: A new potentiator of insulin action: post-receptor activation in vitro. FEBS Lett 163:50-53, 1983
19. Born GVR: Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194:927-929, 1962
20. 32P incorporation into phosphoinositides. Biochim Biophys Acta 710:332-340, 1982
21. Bligh EG, Dyer WJ: Rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917, 1959
22. Jolles J, Schrama LH, Gispen WH: Calcium-dependent turnover of brain polyphosphoinositides in vitro after prelabelling in vivo. Biochem Biophys Acta 666:90-98, 1981
23. Ishizuka T, Cooper DR, Hemandez H, Buckley D, Standaert M, Farese RV: Effect of insulin on diacylglycerol-protein kinase C signaling in rat diaphragm and soleus muscles and relationship to glucose transport Diabetes 39:181-190, 1990
24. Ishizuka T, Cooper DR, Farese RV: Insulin stimulates the translocation of protein kinase C in rat adipocytes. FEBS Lett 257:337-340, 1989
25. Shibasaki F, Homma Y, Takenawa T: Two types of phosphatidylinositol 3-kinase from bovine thymus: monomer and heterodimer form. J Biol Chem 266:8108-8114, 1991
26. Ishizuka T, Taniguchi O, Yamamoto M, Kajita K, Nagashima T, Takeda N, Inouye H, Yasuda K, Miura K: Thrombin-induced platelet aggregation, phosphoinositide metabolism and protein phosphorylation in NIDDM patients treated by diet, sulphonylurea or insulin. Diabetologia 37:632-638, 1994
27. Kovacsovics TJ, Bchelot C, Toker A, Vlahos CJ, Duckworth B, Cantley LC, Hartwig JH: Phosphoinositide 3-kinase inhibition spares actin assembly in activating platelet aggregation. J Biol Chem 270:11358-11366, 1995
28. Zhang JU, Zhang JI, Shattil SJ, Cunningham MC, Rittenhouse SE: Phosphoinositide 3-kinase γ and p85/phosphoinositide 3-kinase in platelet. J Biol Chem 271:6265-6272, 1996
29. Sizer KM, Smith CL, Jacob CS, Swanson ML, Bleasdale JE: Pioglitazone promotes insulin-induced activation of phosphoinositide 3-kinase in 3T3-L1 adipocytes by inhibiting a negative control mechanism. Mol Cell Endocrinol 102:119-129, 1994
30. Zhang B, Szalkowski D, Diaz E, Hayes N, Smith R, Berger J: Potentiation of insulin stimulation of phosphatidylinositol 3-kinase by thiazolidinedione-derived antidiabetic agents in Chinese hamster ovary cells overexpressing human insulin receptors and L6 myotubes. J Biol Chem 269:25735-25741, 1994
31. Freedman JE, Farhat JH, Loscalzo J, Keaney Jr JF: α-Tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Circulation 94:2434-2440, 1996
32. Boscoboinik D, Szewczyk A, Hensey C, Azzi A: Inhibition of cell proliferation by α-tocopherol. J Biol Chem 266:6188-6194, 1991
33. Kunisaki M, Bursell S-E, Clemont AC, Ishii H, Ballas LM, Jirousek MR, Umeda F, Nawata H, King GL: Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-protein kinase C pathway. Am J Physiol 269:E239-E246, 1995